Merck (MRK) Accumulated Expenses (2009 - 2011)

Merck (MRK) has 3 years of Accumulated Expenses data on file, last reported at $8.6 billion in Q1 2011.

• Accumulated Expenses for Q1 2011 came in at $8.6 billion, up 1.37% year-over-year; the trailing twelve-month figure through Mar 2011 was $8.6 billion (up 1.37% YoY), and the FY2010 annual result was $8.5 billion, down 9.95% from the prior year.
• Accumulated Expenses held at $8.6 billion in Q1 2011 per MRK's latest filing, from $8.5 billion in the prior quarter.
• Over five years, Accumulated Expenses peaked at $9.5 billion in Q4 2009 and troughed at $828.0 million in Q2 2009.
• A 3-year average of $6.5 billion and a median of $8.3 billion in 2010 frame the typical range for Accumulated Expenses.
• On a YoY basis, Accumulated Expenses climbed as much as 743.8% in 2010 and fell as far as 9.95% in 2010.
• A 3-year view of Accumulated Expenses shows it stood at $9.5 billion in 2009, then declined by 9.95% to $8.5 billion in 2010, then advanced by 0.48% to $8.6 billion in 2011.
• Business Quant data shows MRK's Accumulated Expenses at $8.6 billion in Q1 2011, $8.5 billion in Q4 2010, and $8.2 billion in Q3 2010.